HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tainted Supplement Warnings Stress FDA’s Enforcement Limitations

This article was originally published in The Tan Sheet

Executive Summary

FDA issued public notifications against 20 products marketed as weight-loss supplements containing the withdrawn Rx ingredient sibutramine.

You may also be interested in...



FDA Supplement Enforcement Priorities Go Beyond NDI Notification

FDA’s plan to tighten enforcement of new dietary ingredient notifications with its controversial guidance still in draft form raises concerns for some stakeholders.

FDA Tainted Supplement Alert Could Set Stage For Rapid Enforcement

A week after FDA warned manufacturers about tighter enforcement against tainted dietary supplements, a MedWatch notice identifies an adulterated weight-loss product that appears to fit the agency's criteria for warranting regulatory action.

FDA Lifts Curtain On The Secret Behind Magic Power Coffee

FDA's consumer advisory against a coffee product that contains an active drug ingredient for erectile dysfunction reflects the agency's growing capability to keep up with noncompliant firms that add drug substances to so-called dietary supplements

Related Content

Topics

UsernamePublicRestriction

Register

RS134124

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel